Head and Neck Squamous Cell Carcinoma (HNSCC)

A Study to See if Giving Fianlimab and Cemiplimab Together is Better Than Cemiplimab Alone at Treating Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

Study of AB598 Monotherapy and Combination Therapy in Participants With Advanced Cancers

[18F]-AraG PET Imaging in LA HNSCC

Postoperative Radiotherapy for Intermediate- and High-risk Patients With HNSCC Greater Than 6 Weeks After Surgery

Nimotuzumab Combined With Immunotherapy and Chemotherapy in the Treatment of Locally Advanced Head and Neck Squamous Cell Carcinoma

A Phase I/IIa Clinical Trial to Investigate BVAC-E6E7 in Subjects With HPV Positive HNSCC.

GEN1042 Safety Trial and Anti-tumor Activity in Participants With Malignant Solid Tumors

A Study to Test Whether Different Combinations of BI 765063, Ezabenlimab, Chemotherapy, Cetuximab, and BI 836880 Help People With Head and Neck Cancer or Liver Cancer

A Phase 1 Study of EPI-326 in EGFR-mutant NSCLC and HNSCC

Study of Safety and Tolerability of Nivolumab Treatment Alone or in Combination With Relatlimab or Ipilimumab in Head and Neck Cancer

Study of Zanzalintinib in Combination With Immuno-Oncology Agents in Participants With Solid Tumors

CCR2 PET Imaging Head and Neck Squamous Cell Carcinoma

Dose Determining Study of EXS74539 (REC-4539) in Participants With Select Solid Tumors

A Study for Identification of Immune Determinants for Response to Nivolumab in Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma

Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing

INBRX-106 in Combination With Pembrolizumab in First-line PD-L1 CPS≥20 HNSCC

[68Ga]Ga-FAPI-46 in Staging of Head and Neck Carcinomas

Reduction of Postoperative Radiotherapy in Head and Neck Squamous Cell Carcinoma

Re-radiotherapy Combined With Chidamide for the Treatment of Recurrent Head and Neck Squamous Cell Carcinoma After Radiotherapy

Study to Assess GTAEXS617 in Participants With Advanced Solid Tumors